News
10 February, 2022 - 19:20 (CET)
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
- BT-CV001 - Tocilizumab - 20mg/mL (Each vial contains 80mg of tocilizumab in 4mL) - Concentrate for solution for infusion - Roche Registration GmbH - GERMANY
- BT-CV002 - Tocilizumab - 20mg/mL (Each vial contains 200mg of tocilizumab in 10mL) - Concentrate for solution for infusion - Roche Registration GmbH - GERMANY
- BT-CV003 - Tocilizumab - 20mg/ml (Each vial contains 400mg of tocilizumab in 20mL) - Concentrate for solution for infusion - Roche Registration GmbH - GERMANY
Related Links